Michael F. DeMane - 30 Sep 2022 Form 4 Insider Report for NEVRO CORP

Role
Director
Signature
/s/ Kashif Rashid, as Attorney-in-Fact for Michael DeMane
Issuer symbol
N/A
Transactions as of
30 Sep 2022
Net transactions value
$0
Form type
4
Filing time
04 Oct 2022, 17:51:28 UTC
Previous filing
05 Jul 2022
Next filing
04 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVRO Common Stock Award $0 +563 +3% $0.000000 19,339 30 Sep 2022 Direct F1, F2
holding NVRO Common Stock 164,344 30 Sep 2022 See footnote F3
holding NVRO Common Stock 82,541 30 Sep 2022 See footnote F4
holding NVRO Common Stock 59,580 30 Sep 2022 See footnote F5
holding NVRO Common Stock 49,911 30 Sep 2022 See footnote F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully vested restricted stock. The restricted stock represent quarterly retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash.
F2 Includes 4,155 restricted stock units. Reflects the transfer of 10,555 directly held shares to the SLAT Trust and 15,569 directly held shares to the 2012 Trust, on January 13, 2022.
F3 Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2012 Irrevocable Trust U/A/D July 26, 2012 (the "2012 Trust").
F4 Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2017 Family SLAT Trust U/A/D May 22, 2017 (the "SLAT Trust").
F5 Shares held by Michael F. DeMane & Catherine Q. DeMane, Trustees, Michael F. DeMane Revocable Trust U/A 10/07/2011 (the "2011 Trust"). Reflects the transfer of 47,980 shares previously held by Michael F. DeMane 2021 Retained Annuity Trust U/A 04/23/2021 to the 2011 Trust on September 14, 2022.
F6 Shares held by Michael F. DeMane, Trustee, Michael F. DeMane 2021 Retained Annuity Trust U/A 08/13/2021.